Covestor
PRAX icon

Covestor’s Praxis Precision Medicines PRAX Stock Holding History

Covestor’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7K Hold
23
– – ﹤0.01% 1739
2026
Q2 		$8K Sell
23
-1
-4% -$317 ﹤0.01% 1741
2026
Q1 		$8K Buy
24
+22
+1,100% +$6.81K 0.01% 1591
2025
Q4 		$1K Hold
2
– – ﹤0.01% 2144
2025
Q3 		$0 Hold
2
– – ﹤0.01% 2655
2025
Q2 		$0 Buy
2
+1
+100% +$38 ﹤0.01% 2634
2025
Q1 		$0 Hold
1
– – ﹤0.01% 2614
2024
Q4 		$0 Buy
+1
New +$72 ﹤0.01% 2623

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Covestor's PRAX Position: Q3 2026 in Review

Covestor held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 23 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Covestor first reported a position in PRAX in Q4 2024 and has held it in 8 quarters since. The position peaked at $8K in Q2 2026. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Covestor held 23 shares of Praxis Precision Medicines worth $7K as of Q3 2026.
  • Covestor left its Praxis Precision Medicines share count unchanged in Q3 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1739 holding.
  • Covestor first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 8 quarters since.
  • Covestor's Praxis Precision Medicines position peaked at $8K in Q2 2026.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.